Author

E. Glukhov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

W. H. Gerwick· 2 shared A. Guild· 1 shared A. J. O'Donoghue· 1 shared A. K. Ecker· 1 shared A. Remmel· 1 shared C. B. Naman· 1 shared E. A. Winzeler· 1 shared E. Boura· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

W. H. Gerwick

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Structure and Biosynthesis of Hectoramide B, a Linear Depsipeptide from the Marine Cyanobacterium Moorena producens JHB Discovered via Co-culture with Candida albicans

T.-E. Ngo, A. K. Ecker, A. Guild, A. Remmel, P. B. Boudreau, K. L. Alexander, C. B. Naman, E. Glukhov, N. E. Avalon, V. V. Shende, L. Gerwick, W. H. Gerwick

This paper identifies hectoramide B, a new linear depsipeptide from Moorena producens JHB, through co-culture with Candida albicans and genome-based biosynthesis analysis.

bioRxiv · Jul 6, 2023 · PreprintBiochemistry

Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity

J. Almaliti, P. Fajtova, J. Calla, G. M. LaMonte, M. Feng, F. Rocamora, S. Ottilie, E. Glukhov, E. Boura, R. T. Suhandynata, J. D. Momper, M. K. Gilson, E. A. Winzeler, W. H. Gerwick, A. J. O'Donoghue

This study develops highly selective epoxyketone-based proteasome inhibitors effective against Plasmodium falciparum with low cytotoxicity to human cells.

bioRxiv · Aug 6, 2022 · PreprintBiochemistry